Birch Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19M Sell
26,641
-368
-1% -$76.3K 2.54% 16
2026
Q1
$6.06M Buy
27,009
+110
+0.4% +$27.4K 3.18% 11
2025
Q4
$6.48M Sell
26,899
-8,642
-24% -$2.21M 3.23% 11
2025
Q3
$9.73M Sell
35,541
-1,314
-4% -$359K 4.96% 4
2025
Q2
$9.51M Buy
36,855
+72
+0.2% +$17.2K 4.87% 5
2025
Q1
$8.23M Buy
36,783
+1,240
+3% +$289K 4.28% 5
2024
Q4
$8.13M Buy
35,543
+6,268
+21% +$1.51M 4.09% 5
2024
Q3
$7.15M Buy
29,275
+2,080
+8% +$465K 3.49% 6
2024
Q2
$5.21M Buy
27,195
+892
+3% +$181K 2.71% 11
2024
Q1
$5.21M Buy
26,303
+355
+1% +$65K 2.71% 12
2023
Q4
$4.46M Hold
25,948
2.56% 14
2023
Q3
$3.84M Hold
25,948
2.43% 15
2023
Q2
$5.67M Sell
25,948
-132
-0.5% -$29.4K 3.45% 7
2023
Q1
$5.71M Hold
26,080
3.68% 7
2022
Q4
$5.43M Hold
26,080
3.74% 9
2022
Q3
$5.69M Sell
26,080
-54
-0.2% -$12.3K 4.3% 7
2022
Q2
$5.48M Hold
26,134
3.91% 9
2022
Q1
$6.34M Sell
26,134
-359
-1% -$86.8K 3.9% 8
2021
Q4
$6.9M Hold
26,493
4.14% 7
2021
Q3
$6.98M Hold
26,493
4.74% 5
2021
Q2
$6.53M Hold
26,493
4.43% 6
2021
Q1
$5.14M Hold
26,493
3.78% 9
2020
Q4
$5.63M Hold
26,493
4.3% 6
2020
Q3
$4.54M Hold
26,493
3.95% 8
2020
Q2
$5.09M Hold
26,493
4.76% 6
2020
Q1
$3.9M Hold
26,493
4.49% 6
2019
Q4
$4.11M Buy
+26,493
New +$3.82M 4.02% 7

Other funds holding RMD

Birch Capital Management's RMD Position: Q2 2026 in Review

Birch Capital Management reduced its ResMed (RMD) stake by 1.4% in Q2 2026, selling an estimated $76.3K and leaving 26,641 shares worth $5.19M. The position accounts for 2.54% of the portfolio, ranked #16.

Birch Capital Management first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.73M in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Birch Capital Management held 26,641 shares of ResMed worth $5.19M as of Q2 2026.
  • Birch Capital Management sold 368 ResMed shares in Q2 2026, an estimated $76.3K.
  • ResMed made up 2.54% of Birch Capital Management's portfolio in Q2 2026, its #16 holding.
  • Birch Capital Management first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
  • Birch Capital Management's ResMed position peaked at $9.73M in Q3 2025.
  • 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Birch Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.